RESUMEN
Higher rates of cancer treatment toxicity and uniquely poor outcomes following a cancer diagnosis have been reported for persons living with HIV (PLWH). This highlights the importance of active HIV status ascertainment in the oncology setting. Self-disclosure of HIV via electronic questionnaire at patient intake is a low-cost option that has not been thoroughly evaluated. We examined 10 years (2009-2019) of patient intake questionnaire data at Moffitt Cancer Center. Self-disclosure of an HIV diagnosis was not uniform, with 36.1% (n = 299, 95% confidence interval [CI] = 32.8% to 39.4%) of 828 patients disclosing. Identification of HIV through this method was highest for anal cancer patients (66.7%, 95% CI = 57.8% to 74.7%). Self-disclosure among patients with hematopoietic malignancies, the most common diagnosis among PLWH at our institution, was lower (19.4%, 95% CI = 14.6% to 25.0%). Patient characteristics associated with HIV self-disclosure included cancer site, natal gender, and race and ethnicity. Findings highlight gaps to motivate future efforts to increase HIV ascertainment prior to initiating cancer care.
Asunto(s)
Instituciones Oncológicas/estadística & datos numéricos , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Admisión del Paciente/estadística & datos numéricos , Autorrevelación , Encuestas y Cuestionarios/estadística & datos numéricos , Adulto , Anciano , Neoplasias del Ano , Intervalos de Confianza , Etnicidad , Femenino , Neoplasias Hematológicas , Humanos , Masculino , Persona de Mediana Edad , Grupos Raciales , Factores SexualesRESUMEN
BACKGROUND: Background: The COVID-19 pandemic and associated containment measures dramatically affected the health care systems including the screening of human immunodeficiency virus and the management people living with HIV around the world by making the access to preventive care services and specific medical monitoring more difficult. OBJECTIVE: Objective: To study the impact of the COVID-19 pandemic on the holistic care of people living with HIV in Liège (Belgium). METHODS: Methods: In this retrospective observational study conducted in Liège University Hospital, we compared the out-patient follow-up of HIV-infected individuals as well as the number of new HIV diagnoses between 2019 and 2020 and between the different waves of the COVID-19 pandemic in 2020. RESULTS: Results: In 2020, when compared to 2019, we observed a significant decrease in the number of new HIV diagnoses, especially during the first wave of the pandemic, and in the number of consultations undertaken by sexual health services, psychologists and specialists in infectious diseases at our HIV clinic. We also observed a decrease in the number of viral load assays and blood CD4 + T-cells count analyses performed, although we found less patients with HIV plasma viral load above 400 copies per mL in 2020. Finally, we noted a significant reduction in terms of screening of our HIV-infected patients for hepatitis C, syphilis, colorectal and anal cancers and hypercholesterolemia. CONCLUSIONS: Conclusions: Our experience exhibits the deleterious impact of the COVID-19 pandemic on the HIV care and the need to implement new strategies to guarantee its continuum.
Asunto(s)
COVID-19/epidemiología , Infecciones por VIH/diagnóstico , Infecciones por VIH/tratamiento farmacológico , Atención Ambulatoria/estadística & datos numéricos , Bélgica/epidemiología , Recuento de Linfocito CD4/estadística & datos numéricos , COVID-19/prevención & control , Coinfección/diagnóstico , Infecciones por VIH/epidemiología , Infecciones por VIH/prevención & control , Sobrevivientes de VIH a Largo Plazo/psicología , Sobrevivientes de VIH a Largo Plazo/estadística & datos numéricos , Humanos , Tamizaje Masivo/estadística & datos numéricos , Derivación y Consulta/estadística & datos numéricos , Estudios Retrospectivos , SARS-CoV-2 , Tiempo de Tratamiento/estadística & datos numéricos , Carga Viral/estadística & datos numéricosRESUMEN
Background To identify reasons for increased atherosclerotic risk among women living with HIV (WLWH), we evaluated the associations between psychosocial risk factors (depressive symptoms, perceived stress, and posttraumatic stress disorder symptoms) and subclinical atherosclerosis among WLWH and HIV-negative women. Methods and Results Carotid artery focal plaque (localized intima-media thickness >1.5 mm) was measured using B-mode ultrasound imaging in 2004-2005 and 2010-2012 in the Women's Interagency HIV Study. We created psychosocial risk groups using latent class analysis and defined prevalent plaque at the final measurement. We also examined repeated semiannual depression measures with respect to focal plaque formation throughout follow-up. The associations between latent class and prevalent plaque, and between depressive symptom persistence and plaque formation, were assessed separately by HIV status using multivariable logistic regression. Among 700 women (median age 47 years), 2 latent classes were identified: high (n=163) and low (n=537) psychosocial risk, with corresponding prevalence of depression (65%/13%), high stress (96%/12%), and probable posttraumatic stress disorder (46%/2%). Among WLWH, plaque prevalence was 23% and 11% in high versus low psychosocial risk classes (adjusted odds ratio [aOR], 2.12; 95% CI, 1.11-4.05) compared with 9% and 9% among HIV-negative women (aOR, 1.07; 95% CI, 0.24-4.84), respectively. New plaque formation occurred among 17% and 9% of WLWH who reported high depressive symptoms at ≥45% versus <45% of visits (aOR, 1.96; 95% CI, 1.06-3.64), compared with 9% and 7% among HIV-negative women (aOR, 0.82; 95% CI, 0.16-4.16), respectively. Conclusions Psychosocial factors were independent atherosclerotic risk factors among WLWH. Research is needed to determine whether interventions for depression and psychosocial stress can mitigate the increased risk of atherosclerosis for WLWH.
Asunto(s)
Enfermedades de las Arterias Carótidas/epidemiología , Depresión/epidemiología , Infecciones por VIH/epidemiología , Sobrevivientes de VIH a Largo Plazo/psicología , Trastornos por Estrés Postraumático/epidemiología , Estrés Psicológico/epidemiología , Adulto , Enfermedades Asintomáticas , Enfermedades de las Arterias Carótidas/diagnóstico por imagen , Grosor Intima-Media Carotídeo , Estudios Transversales , Depresión/diagnóstico , Depresión/psicología , Femenino , Infecciones por VIH/diagnóstico , Infecciones por VIH/psicología , Humanos , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos , Medición de Riesgo , Factores de Riesgo , Factores Sexuales , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/psicología , Estrés Psicológico/diagnóstico , Estrés Psicológico/psicología , Factores de Tiempo , Estados Unidos/epidemiologíaRESUMEN
Young people living with perinatally acquired HIV may be at risk of poor adherence to antiretroviral therapy; identification of predictors, using a conceptual framework approach proposed previously by others, is important to identify those at higher risk. In 261 young people with perinatally acquired HIV in England, 70 (27%) reported 3-day nonadherence, 82 (31%) last month nonadherence, and 106 (41%) nonadherence on either measure. Of those reporting nonadherence on both measures, 52% (23/44) had viral load of <50 copies/ml, compared with 88% (127/145) of those reported being fully adherent. In multivariable analysis, young person and medication theme factors were associated with nonadherence. The main predictors of 3-day nonadherence were antiretroviral therapy containing a boosted protease inhibitor and poorer quality of life. Predictors of last month nonadherence were having told more people about one's HIV status, worse self-perception about having HIV, and boosted protease inhibitor-based regimens. The consistency of individual young person and medication factors in predicting nonadherence gives insight into where interventions may best be targeted to improve adherence.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Terapia Antirretroviral Altamente Activa/estadística & datos numéricos , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , Sobrevivientes de VIH a Largo Plazo/psicología , Cumplimiento de la Medicación/estadística & datos numéricos , Calidad de Vida/psicología , Adolescente , Estudios de Cohortes , Inglaterra/epidemiología , Femenino , Infecciones por VIH/epidemiología , Humanos , Masculino , Cumplimiento de la Medicación/psicología , Prevalencia , Estudios Prospectivos , Encuestas y Cuestionarios , Carga ViralRESUMEN
BACKGROUND: People living with HIV who were diagnosed before highly active antiretroviral therapy became available in 1996 and who survived at least 15 years after HIV diagnosis, termed long-term survivors (LTS), form a particularly vulnerable population. We study social, clinical and mental factors of LTS in the Swiss HIV Cohort Study, with a particular focus on people who inject drugs (PWID). METHODS: We quantified differences between PWID LTS, and men who have sex with men (MSM) and heterosexual (HET) LTS. Using phylogenetic methods, we distinguished between heterosexual LTS who most likely shared a social network with PWID at the time of infection, termed clusteredHET, and those who did not, termed HET not clustered (HETnc). The analysis was performed using data collected at least 15 years post diagnosis. RESULTS: Overall, 1,663 of 5,686 (29.2%) PWID were LTS. We found significant differences between PWID LTS and MSM/HETnc LTS regarding self-reported depression (59.4% versus 43.3%; odds ratio [OR]=1.8; P<0.001), incarceration (30.6% versus 7.0%; OR=6.9; P<0.001) and full work ability (25.4% versus 59.0%; OR=0.27; P<0.001). ClusteredHET were less vulnerable with respect to these variables than PWID LTS but more at risk compared with MSM/HETnc LTS, indicating that clusteredHET are closer to PWID with regard to social and mental aspects compared with all MSM/HETnc. CONCLUSIONS: Even more than 15 years post HIV diagnosis, special care for HIV-positive PWID is needed, with emphasis on mental health and social integration of PWID LTS.
Asunto(s)
Ajuste Emocional , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Abuso de Sustancias por Vía Intravenosa/psicología , Femenino , Infecciones por VIH/complicaciones , Infecciones por VIH/etiología , Sobrevivientes de VIH a Largo Plazo/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Psicología , Abuso de Sustancias por Vía Intravenosa/complicaciones , SuizaRESUMEN
Cardiovascular disease (CVD) is an increasingly important cause of morbidity and mortality among people living with HIV (PLWH) now that HIV is a manageable chronic disease. Identification and treatment of comorbid medical conditions for PLWH, including CVD and its risk factors, typically lack a critical component of care: integrated care for histories of trauma. Experiences of trauma are associated with increased HIV infection, CVD risk, inconsistent treatment adherence, and poor CVD outcomes. To address this deficit among those at greatest risk and disproportionately affected by HIV and trauma-i.e., Black and Latinx individuals-a novel culturally-congruent, evidence-informed care model, "Healing our Hearts, Minds and Bodies" (HHMB), has been designed to address patients' trauma histories and barriers to care, and to prepare patients to engage in CVD risk reduction. Further, in recognition of the need to ensure that PLWH receive guideline-concordant cardiovascular care, implementation strategies have been identified that prepare providers and clinics to address CVD risk among their Black and Latinx PLWH. The focus of this paper is to describe the hybrid Type 2 effectiveness/implementation study design, the goal of which is to increase both patient and organizational readiness to address trauma and CVD risk among 260 Black and Latinx PLWH recruited from two HIV service organizations in Southern California. This study is expected to produce important information regarding the value of the HHMB intervention and implementation processes and strategies designed for use in implementing HHMB and other evidence-informed programs in diverse, resource-constrained treatment settings, including those that serve patients living in deep poverty. Clinical trials registry: NCT04025463.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Negro o Afroamericano/psicología , Enfermedades Cardiovasculares/prevención & control , Asistencia Sanitaria Culturalmente Competente/organización & administración , Infecciones por VIH/tratamiento farmacológico , Sobrevivientes de VIH a Largo Plazo/psicología , Conocimientos, Actitudes y Práctica en Salud/etnología , Hispánicos o Latinos/psicología , Salud Mental/etnología , Aceptación de la Atención de Salud/etnología , Servicios Preventivos de Salud/organización & administración , Adolescente , Adulto , Anciano , Fármacos Anti-VIH/efectos adversos , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/etnología , Enfermedades Cardiovasculares/psicología , Femenino , Infecciones por VIH/diagnóstico , Infecciones por VIH/etnología , Infecciones por VIH/psicología , Estado de Salud , Humanos , Los Angeles/epidemiología , Masculino , Persona de Mediana Edad , Modelos Organizacionales , Factores Protectores , Factores Raciales , Proyectos de Investigación , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Carga Viral , Adulto JovenRESUMEN
Cardiovascular disease (CVD) is a major cause of morbidity among people living with HIV (PLWH). Statins can safely and effectively reduce CVD risk in PLWH, but evidence-based statin therapy is under-prescribed in PLWH. Developed using an implementation science framework, INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) is a stepped-wedge cluster randomized trial that addresses organization-, clinician- and patient-level barriers to statin uptake in Los Angeles community health clinics serving racially and ethnically diverse PLWH. After assessing knowledge about statins and barriers to clinician prescribing and patient uptake, we will design, implement and measure the effectiveness of (1) educational interventions targeting leadership, clinicians, and patients, followed by (2) behavioral economics-informed clinician feedback on statin uptake. In addition, we will assess implementation outcomes, including changes in clinician acceptability of statin prescribing for PLWH, clinician acceptability of the education and feedback interventions, and cost of implementation.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Actitud del Personal de Salud , Enfermedades Cardiovasculares/prevención & control , Economía del Comportamiento , Infecciones por VIH/tratamiento farmacológico , Sobrevivientes de VIH a Largo Plazo/psicología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Pautas de la Práctica en Medicina , Servicios Preventivos de Salud , Fármacos Anti-VIH/efectos adversos , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/psicología , Prescripciones de Medicamentos , Educación Médica Continua , Infecciones por VIH/diagnóstico , Infecciones por VIH/epidemiología , Infecciones por VIH/psicología , Conocimientos, Actitudes y Práctica en Salud , Estado de Salud , Humanos , Ciencia de la Implementación , Capacitación en Servicio , Los Angeles/epidemiología , Cumplimiento de la Medicación , Estudios Multicéntricos como Asunto , Educación del Paciente como Asunto , Factores Protectores , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Carga ViralRESUMEN
OBJECTIVE: Little is known about pregnancy outcomes among women who have acquired human immunodeficiency virus (HIV) through perinatal infection and survived into adulthood. The objectives of this study were to describe pregnancy outcomes among women with perinatal HIV infection (PHIV) in Canada and to identify potential challenges in the prevention of perinatal HIV transmission in this population. METHODS: A retrospective review of all pregnancies among women with PHIV who were previously followed as children at two tertiary care centres in Montréal, Québec, was conducted. Data were extracted from pediatric and obstetrical records. RESULTS: There were 21 pregnancies among 11 women, and 18 of these pregnancies were unintentional. Mean age at first pregnancy was 19.5 years (range 15-29 years). At the first prenatal visit, 79% had a detectable viral load, 36% were immunosuppressed (CD4 T cell count <200 mm3), and only 36% were receiving antiretroviral therapy (ART). At the time of delivery, although all were prescribed ART, 50% of these women still had a detectable viral load, and 36% remained immunosuppressed. All of the women harboured mutations conferring drug resistance to zidovudine and lamivudine, and the majority (73%) were also resistant to nevirapine. None of the infants were HIV infected, although all received prophylaxis with agents to which their mother's virus was resistant. CONCLUSION: Unplanned pregnancies, difficulties with adherence to ART, and drug resistance were identified challenges in the management of pregnancies among women with PHIV. This study highlights a gap in the reproductive counselling of adolescents with PHIV and the need for close follow-up and adherence support during pregnancy in this population.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Terapia Antirretroviral Altamente Activa/métodos , Infecciones por VIH/tratamiento farmacológico , Sobrevivientes de VIH a Largo Plazo/psicología , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Embarazo no Planeado , Adolescente , Adulto , Canadá/epidemiología , Femenino , Infecciones por VIH/epidemiología , Infecciones por VIH/transmisión , Sobrevivientes de VIH a Largo Plazo/estadística & datos numéricos , Humanos , Lactante , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Cumplimiento de la Medicación/psicología , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Quebec/epidemiología , Estudios Retrospectivos , Carga Viral , Adulto Joven , Zidovudina/uso terapéuticoRESUMEN
A aids é uma doença infectocontagiosa que se tornou uma realidade a partir dos anos 1980. Desde o início da epidemia de HIV/aids, quando os corpos das Pessoas vivendo com HIV/aids (PVHA) eram caracterizados pela magreza extrema, as imagens corporais das PVHA vêm sofrendo modificações. Com o início do tratamento para o HIV/aids, após 1996, os corpos deixaram de ser caracterizados pela magreza e novos desafios foram se apresentando, seja em consequência do diagnóstico, da longevidade, do exercício da sexualidade ou do tratamento medicamentoso tendo na adesão e, sobretudo, na lipodistrofia - uma síndrome que produz a má distribuição de gordura corporal - seu maior expoente. Esta tese buscou compreender os sentidos atribuídos aos corpos das PVHA a partir das narrativas de vida de Bertaux (2010). Escutei 24 interlocutores, de ambos os sexos, de distintas idades e gerações e que se infectaram de variadas formas e realizei trabalho de campo em distintos cenários. Desta forma, pude conversar, entrevistar e interagir com muitas pessoas que se dispuseram a relatar, comentar e compartilhar comigo suas memórias. Optei por trazer suas narrativas sempre que pude, aliando à sua expressividade, vez por outra, outros "insigths" interpretativos. Para além da Lipodistrofia - presente em toda a tese, seja nos corpos presentes, seja enquanto reminiscências -, o corpo está presente no trabalho através dos relatos de modificações corporais, representações sobre o peso, o envelhecimento, o contato com outros corpos, as cicatrizes de doenças oportunistas, e mesmo nas tentativas de apagamento de qualquer sinal de desvelamento do vírus corporalmente, através do preenchimento facial e de tatuagens. E, mesmo não sendo um estudo que teve como objeto central o estigma, é digno de nota assinalar que este tema atravessou praticamente todos os capítulos.
AIDS is an infectious and contagious disease that became a reality in the 1980s. Since the beginning of the HIV / AIDS epidemic, the body images of people living with HIV / AIDS (PLWHA) have been changing, the bodies of PLWHA were characterized for extreme thinness. With the start of treatment for HIV / AIDS after 1996, bodies are no longer characterized by thinness, and new challenges have been presented, whether as a result of diagnosis, longevity, the exercise of sexuality and drug treatment - with adherence and, above all, in lipodystrophy - a syndrome that produces the poor distribution of body fat - its greatest exponent. This thesis sought to understand the meanings attributed to the bodies of people living with HIV / AIDS from the narratives of Bertaux's life (2010). I listened to 24 interlocutors, of both sexes, of different ages and generations, who were contaminated in various ways and carried out fieldwork in different scenarios. In this way, I was able to talk, interview and interact with many people who were willing to report, comment and share their memories with me. I chose to bring their narratives whenever I could, combining their expressiveness, from time to time, other interpretive "insigths" occurred. In addition to Lipodystrophy - present throughout the thesis, whether in the bodies present or as reminiscences -, the body is present at work through reports of bodily changes, representations about weight, aging, contact with other bodies, scars opportunistic diseases, and even in attempts to erase any sign of unveiling of the virus bodily, through facial filling and tattoos. And, even though it is not a study that had stigma as its central object, it is worth noting that this theme crossed practically all the chapters.
Asunto(s)
Humanos , Encuestas y Cuestionarios , Síndrome de Inmunodeficiencia Adquirida/terapia , Sobrevivientes de VIH a Largo Plazo/psicología , Síndrome de Lipodistrofia Asociada a VIH , Antirretrovirales/uso terapéutico , Estigma SocialRESUMEN
BACKGROUND: The global HIV burden among adolescents ages 10-19 is growing. This population concurrently confronts the multifaceted challenges of adolescence and living with HIV. With the goal of informing future interventions tailored to this group, we assessed sexual activity, HIV diagnosis disclosure, combination antiretroviral therapy (cART) adherence, and drug use among adolescents living with HIV (ALHIV) in Lima, Peru. METHODS: Adolescents at risk or with a history of suboptimal cART adherence completed a self-administered, health behaviors survey and participated in support group sessions, which were audio recorded and used as a qualitative data source. Additionally, we conducted in-depth interviews with caregivers and care providers of ALHIV. Thematic content analysis was performed on the group transcripts and in-depth interviews and integrated with data from the survey to describe adolescents' health related behaviors. RESULTS: We enrolled 34 ALHIV, of which 32 (14 male, 18 female, median age 14.5 years) completed the health behavior survey. Nine (28%) adolescents reported prior sexual intercourse, a minority of whom (44%) reported using a condom. cART adherence was highest in the 10-12 age group with 89% reporting ≤2 missed doses in the last month, compared to 36% in adolescents 13 years or older. Over 80% of adolescents had never disclosed their HIV status to a friend or romantic partner. Adolescents, caregivers, and health service providers described sexual health misinformation and difficulty having conversations about sexual health and HIV. CONCLUSIONS: In this group of ALHIV, adherence to cART declined with age and condom use among sexually active adolescents was low. Multifactorial interventions addressing sexual health, gaps in HIV-related knowledge, and management of disclosure and romantic relationships are urgently needed for this population.
Asunto(s)
Infecciones por VIH/tratamiento farmacológico , Sobrevivientes de VIH a Largo Plazo/estadística & datos numéricos , Conductas Relacionadas con la Salud , Autorrevelación , Conducta Sexual/estadística & datos numéricos , Adolescente , Conducta del Adolescente , Factores de Edad , Antirretrovirales/uso terapéutico , Niño , Condones/estadística & datos numéricos , Análisis de Datos , Femenino , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Humanos , Relaciones Interpersonales , Masculino , Cumplimiento de la Medicación/estadística & datos numéricos , Perú/epidemiología , Investigación Cualitativa , Grupos de Autoayuda , Medio Social , Trastornos Relacionados con Sustancias/epidemiologíaRESUMEN
The concept of successful aging was recognized only recently by HIV researchers because people living with HIV (PLWH) in the early epidemic were not expected to survive. With the introduction of antiretrovirals that block viral replication, PLWH are now aging with HIV. Given the complex nature of HIV within the social, economic, and political climates in which it occurs, a holistic model of successful aging is needed to guide researchers and clinicians. Several overarching models exist, but must be updated for rapidly advancing HIV and aging research agendas. We provide an updated, adapted, and integrated biopsychosocial model of successful aging with HIV based on the principles of Baltes and Baltes (1998) on 8 essential components of successful aging: (a) length of life, (b) biological health, (c) mental health, (d) cognitive efficiency, (e) social competence, (f) productivity, (g) personal control, and (h) life satisfaction. Clinical practice and research implications are highlighted.
Asunto(s)
Envejecimiento/psicología , Fármacos Anti-VIH/uso terapéutico , Terapia Antirretroviral Altamente Activa , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Salud Mental , Satisfacción Personal , Calidad de Vida/psicología , Anciano , Anciano de 80 o más Años , Envejecimiento/fisiología , Fármacos Anti-VIH/efectos adversos , Terapia Antirretroviral Altamente Activa/efectos adversos , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/epidemiología , Trastornos del Conocimiento/psicología , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/fisiopatología , Humanos , Longevidad/efectos de los fármacos , Ajuste SocialAsunto(s)
Envejecimiento/fisiología , Envejecimiento/psicología , Atención a la Salud/organización & administración , Epidemias , Geriatría/organización & administración , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Política de Salud , Factores de Edad , Fármacos Anti-VIH/uso terapéutico , Discriminación en Psicología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/epidemiología , Humanos , Estigma Social , Apoyo SocialRESUMEN
As the number of persons living with HIV (PLWH) will continue to increase in the coming years, it is critical to understand factors influencing appropriate nursing home (NH) care planning. This study described the sociodemographic characteristics as well as the antiretroviral therapy treatment and physical and mental health among Medicare-eligible PLWH in NHs. Persons living with HIV were identified and summarized using a 2011-2013 nationwide data set of Medicare claims linked to NH resident health assessments and a prescription dispensing database, comparing new admissions in 2011-2013 with those from 1998 to 2000. We identified 7,188 PLWH from 2011 to 2013 in NHs of whom 4,031 were newly admitted. Of the total, 79% were prescribed antiretroviral therapy. Most were male (73%), Black/African American (51.1%), and a plurality resided in southern NHs (47%). Comparing the data sets, new admissions were older (60 vs. 44), had higher prevalence of viral hepatitis (16.2% vs. 7.5%), and anemia (31.1% vs. 25.1%) but had less pneumonia (11.0% vs. 13.6%) and dementia (8.7% vs. 21.0%). NH nurses can better anticipate health care needs of PLWH using these health profiles, understanding that there have been changes in the health of PLWH at admission over time.
Asunto(s)
Infecciones por VIH/epidemiología , Sobrevivientes de VIH a Largo Plazo/estadística & datos numéricos , Medicare/estadística & datos numéricos , Casas de Salud/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Anemia/epidemiología , Fármacos Anti-VIH/uso terapéutico , Comorbilidad , Estudios Transversales , Demencia/epidemiología , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Hepatitis Viral Humana/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Neumonía/epidemiología , Prevalencia , Estados Unidos/epidemiologíaRESUMEN
Palm Springs, CA, is a retirement community with the highest prevalence of gay men living with HIV older than 50 years in the United States. Through a community-academic partnership, we explored the major health issues, resiliencies, and priority research topics related to HIV and aging. We conducted five community facilitated focus groups with different stakeholders, including two focus groups with older adults living with HIV, one with their caregivers, one with HIV-focused community-based organizations, and a joint focus group with researchers and HIV care providers. Using the rigorous and accelerated data reduction technique, five major themes emerged, which included long-term side effects of medication, social determinants of health, mental health, resiliencies, and involving community in research. These data are important for developing effective interventions, conducting useful and impactful research, and providing health care providers with the tools and knowledge to provide optimal care.
Asunto(s)
Fármacos Anti-VIH/efectos adversos , Cuidadores/psicología , Relaciones Comunidad-Institución , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Personal de Salud/psicología , Prioridades en Salud , Envejecimiento Saludable , Adulto , Anciano , Fármacos Anti-VIH/uso terapéutico , Investigación Participativa Basada en la Comunidad , Femenino , Grupos Focales , Infecciones por VIH/tratamiento farmacológico , Humanos , Soledad , Masculino , Persona de Mediana Edad , Salud Pública , Investigación Cualitativa , Determinantes Sociales de la Salud , Apoyo SocialRESUMEN
BACKGROUND: Patients with human immunodeficiency virus (HIV) infection have higher rates of cardiovascular disease, metabolic disorders and malignancy than their uninfected peers. AIM: To survey the health of a South Australian cohort of long-term HIV patients, who had been diagnosed with HIV prior to the availability of combination antiretroviral therapy. METHODS: Data from 88 patients were collected retrospectively across four domains: demographics, HIV history, antiretroviral medication and medical comorbidity. RESULTS: There were high rates of cardiovascular risk factors, in particular active smoking, dyslipidaemia and diabetes mellitus, which translated into a high rate of ischaemic heart disease and cerebrovascular accidents. A large proportion of the patients suffered depression and cognitive impairment. Approximately one-fifth of the cohort had been diagnosed with a malignancy, with anal cancer being the most prevalent. Many patients had experienced permanent toxicity from antiretroviral therapy. CONCLUSION: The present study showed high rates of 'non-HIV morbidity' in a group of long-term HIV patients in South Australia. Clinicians should aggressively modify cardiovascular risk factors, ensure appropriate immunisations, monitor mental health and consider targeted malignancy screening in these patients. A robust clinical infrastructure and multidisciplinary team is required to facilitate the complex care needs of long-term HIV patients.
Asunto(s)
Infecciones por VIH/epidemiología , Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Estado de Salud , Anciano , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/psicología , Estudios de Cohortes , Comorbilidad , Femenino , Infecciones por VIH/diagnóstico , Humanos , Masculino , Enfermedades Metabólicas/diagnóstico , Enfermedades Metabólicas/epidemiología , Enfermedades Metabólicas/psicología , Persona de Mediana Edad , Estudios Retrospectivos , Australia del Sur/epidemiología , Factores de TiempoRESUMEN
BACKGROUND: The aim of this longitudinal study was to examine the consistency of health-related quality of life (HRQoL) among people living with HIV (PLWH) by breaking down the variance of repeated HRQoL measures into trait, state, and method components and to test the stability of HRQoL over time. In addition, we wanted to examine whether HRQoL trait components are related to personality traits, while controlling for selected socio-medical variables. METHODS: Three assessments were performed with a six-month lag on each assessment. Each participant filled out a World Health Organization (WHO) Quality of Life-BREF to assess HRQoL and a NEO-FFI to measure Big Five personality traits. Overall, 82 participants out of 141 (58.2% of the initial sample) participated in all the assessments. RESULTS: The HRQoL among PLWH represented a stable trait to a somewhat greater extent than a situational variability, although the proportions were domain and time variant. More specifically, psychological domain appeared to be the most consistent, whereas social domain appeared to be the most prone to situational influences. The trait component of HRQoL was positively related to being in a relationship, being employed, and being extraverted, and negatively related to neuroticism, which altogether explained 26% of the trait variance. CONCLUSIONS: HRQoL among PLWH is rather distinct from personality and socio-medical data, which indicates its uniqueness in a clinical practise. Thus, there is a need for a more comprehensive assessment of HRQoL among this patient group to capture an additional source of variance in this important theoretical construct.
Asunto(s)
Infecciones por VIH/psicología , Sobrevivientes de VIH a Largo Plazo/psicología , Personalidad/clasificación , Calidad de Vida/psicología , Adulto , Anciano , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Inventario de Personalidad , Apoyo Social , Adulto JovenRESUMEN
The National Institutes of Health human immunodeficiency virus (HIV) and Aging Working Group identified spirituality as a research emphasis. This qualitative study examines the importance of religion and spirituality among 30 HIV-positive older adults. Using modified grounded theory, adults 50+ were recruited in Ontario, Canada, through AIDS service organizations, clinics, and community agencies. Descriptions of religion and spirituality encapsulated the idea of a journey, which had two components: the long-term HIV survivor profile combined with the experience of aging itself. A final category of HIV as a spiritual journey was finalized through consensus and included the properties of (1) being rejected by as well as rejection of formalized religion, (2) differentiating spirituality from religion, (3) having a connection, (4) feeling grateful, and (5) mindfulness and learning new skills. Interventions fostering resilience and strengths in HIV-positive older adults using spirituality should be considered, including the promotion of person-centered spirituality and interventions that include mindfulness and skill building.
Asunto(s)
Infecciones por VIH/psicología , Envejecimiento Saludable , Religión , Espiritualidad , Anciano , Femenino , Teoría Fundamentada , Sobrevivientes de VIH a Largo Plazo/psicología , Humanos , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Atención Plena , Ontario , Investigación CualitativaRESUMEN
OBJECTIVE: To analyze whether socioeconomic and clinical aspects and the aspects of healthy life habits are associated with the quality of life of persons living with HIV/AIDS. METHODS: This is a cross-sectional exploratory quantitative research, with 227 persons living with HIV/AIDS, treated at two hospitals of reference between April 2012 and June 2014. We used structured questionnaires to assess socioeconomic aspects (gender, age, education level, marital status, race, socioeconomic status, dependents on family income, employment relationship), clinical parameters (time of disease diagnosis, use and time of medication, CD4 T-cell count, and viral load), and practice of physical exercise. To assess quality of life, we used the Quality of Life questionnaire (HAT-QoL). For characterization of the socioeconomic and clinical data and domains of quality of life, we conducted a descriptive analysis (simple frequency, averages, and standard deviations). We applied linear regression, following a hierarchical model for each domain of quality of life. RESULTS: The domains that presented lower averages for quality of life were financial concern, concern with confidentiality, general function, and satisfaction with life. We found associations with the variables of socioeconomic status and physical exercise, therapy, and physical exercise for the last two domains, consecutively. CONCLUSIONS: The quality of life of persons living with HIV/AIDS shows losses, especially in the financial and confidentiality areas, followed by general function of the body and satisfaction with life, in which socioeconomic and clinical aspects and healthy living habits, such as the practice of physical exercise, are determining factors for this reality. OBJETIVO: Analisar se aspectos socioeconômicos, clínicos e de hábitos de vida saudável estão associados à qualidade de vida em pessoas vivendo com HIV/aids. MÉTODOS: Pesquisa quantitativa exploratória de corte transversal, com 227 pessoas vivendo com HIV/aids, atendidos em dois hospitais de referência entre os períodos de abril 2012 a junho de 2014. Foram utilizados questionários estruturados para avaliar aspectos socioeconômicos (sexo, idade, escolaridade, estado civil, cor de pele, status socioeconômico, dependentes da renda familiar, vínculo empregatício), parâmetros clínicos (tempo de diagnóstico da doença, uso e tempo de medicação, contagem de células TCD4 e carga viral) e prática de exercício físico. Para avaliar qualidade de vida, utilizou-se o questionário Quality of Life (HAT-QoL). Para caracterização dos dados socioeconômicos, clínicos e domínios da qualidade de vida, conduzimos análise descritiva (frequência simples, médias e desvios-padrão). Aplicamos regressão linear, seguindo um modelo hierárquico para cada domínio da qualidade de vida. RESULTADOS: Os domínios que apresentaram menores médias para a qualidade de vida foram preocupação financeira, preocupação com sigilo, função geral e satisfação com a vida. Foram encontradas associações com as variáveis status socioeconômico e exercício físico; terapia; e exercício físico para os dois últimos domínios, consecutivamente. CONCLUSÕES: A qualidade de vida de pessoas vivendo com HIV/aids apresentam prejuízos, principalmente nas questões financeiras e de sigilo, seguidos da função geral do corpo e satisfações com a vida, em que os aspectos socioeconômicos, clínicos e hábitos de vida saudável, como a prática de exercício físico, são fatores determinantes para essa realidade.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/fisiopatología , Ejercicio Físico/fisiología , Sobrevivientes de VIH a Largo Plazo , Calidad de Vida , Síndrome de Inmunodeficiencia Adquirida/psicología , Síndrome de Inmunodeficiencia Adquirida/rehabilitación , Adulto , Brasil , Recuento de Linfocito CD4 , Estudios Transversales , Femenino , Sobrevivientes de VIH a Largo Plazo/psicología , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Calidad de Vida/psicología , Factores Socioeconómicos , Encuestas y Cuestionarios , Factores de Tiempo , Carga ViralRESUMEN
Telepsychology research has focused primarily on treatment efficacy, with far less attention devoted to how common factors relate to teletherapy outcomes. This research identified trajectories of depressive symptom relief in 105 older people living with HIV with elevated depressive symptoms enrolled in a randomized clinical trial testing two 12-session group teletherapies and compared common factors (e.g., therapeutic alliance and group cohesion) across depressive symptom trajectory groups. Growth mixture modelling of weekly depression scores identified three depressive symptom change groups: (1) 'early improvers' (31%) who reported reductions in depressive symptoms by Session 4; (2) 'delayed improvers' (16%) whose symptoms improved after Session 5 and (3) 'non-improvers' (53%). Therapeutic alliance was unrelated to treatment outcome group. Group cohesion was greater in early improvers than non-improvers. Group cohesion was unexpectedly lower, and group member similarity was greater in delayed improvers than non-improvers. Early improvers had been living with HIV/AIDS for fewer years than non-improvers. In group teletherapy, group cohesion and group member similarity are more important than client-therapist alliance. Copyright © 2015 John Wiley & Sons, Ltd. KEY PRACTITIONER MESSAGE: In group teletherapy with older people living with HIV (OPLWHIV), three latent outcome trajectory groups emerged over the 12-week treatment period: (1) non-improvers (53%); (2) early improvers (31%) and (3) delayed improvers (16%). In group teletherapy with OPLWHIV, group cohesion is a stronger predictor of depressive symptom relief than is client-therapist alliance. OPLWHIV in group teletherapy who do not respond to treatment until the latter therapy sessions can still experience depressive symptom relief comparable with early responders.